ClinicalTrials.Veeva

Menu

Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant

Vanderbilt University logo

Vanderbilt University

Status

Completed

Conditions

Graft vs Host Disease
Hematopoietic Stem Cell Transplantation

Study type

Observational

Funder types

Other

Identifiers

NCT00179049
BMT 030261

Details and patient eligibility

About

The investigators' hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the complications of graft-versus-host disease.

Full description

The investigators' hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the complications of graft-versus-host disease (GVHD) by determining the qualitative and quantitative changes in T regulatory cells throughout the transplant process. Their understanding of this can lead to new treatment strategies and improved clinical therapeutic implications.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients 18-70 years old undergoing either autologous transplant or allogeneic transplant for various hematologic conditions

Exclusion criteria

  • Patients < 18 or > 70 years old undergoing either autologous transplant or allogeneic transplant

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems